• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小而密低密度脂蛋白浓度与血清载脂蛋白B密切相关,非低密度脂蛋白胆固醇或低密度脂蛋白胆固醇的比较]

[Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].

作者信息

Hayashi Toshiyuki, Hirano Tsutomu, Shiobara Tomomi, Suguro Toshiaki, Adachi Mitsuru

机构信息

First Department of Internal Medicine, Showa University School of Medicine, Tokyo.

出版信息

Rinsho Byori. 2006 Jun;54(6):569-75.

PMID:16872005
Abstract

Small dense low-density lipoprotein (sd LDL) is more atherogenic than large buoyant (lb) LDL, which is relatively high in particle number (as estimated by apolipoprotein [apo] B) and poor in cholesterol (C) content. Because recent epidemiological studies have shown that serum apo B is a stronger predictor of the risk of coronary heart disease (CHD) than LDL-C, we assumed that this strong predictive power of apo B for CHD is attributable to a close association with sd LDL concentration. On the other hand, non-HDL-C has been proposed as an integrated CHD risk marker containing all atherogenic apo B-containing lipoproteins. We examined which apo B or non-HDL-C is superior marker in reflecting sd-LDL particles. Eighty-one subjects with dyslipidemia were studied. Sd LDL (density, 1.044 approximately .063g/ml) and large buoyant LDL (density, 1.019 approximately 1.044g/ml) were separated by the ultracentrifugation method and LDL size was measured by gradient gel electrophoresis. LDL-C, non-HDL-C, and apo B were highly associated with each other(r=0.78 approximately 0.87), and all were associated with C, apo B, and TG in sd-LDL. However, multivariate regression analysis revealed that only apo B was constantly and independently associated with sd-LDL concentrations. Mean LDL diameter was negatively associated with apo B but not with non-HDL-C. These results suggest that apo B is superior to non-HDL-C in reflecting a potent atherogenic lipoprotein, sd-LDL, which may explain a potent predictive power of apo B for CHD.

摘要

小而密的低密度脂蛋白(sd LDL)比大而轻的(lb)LDL更具致动脉粥样硬化性,后者的颗粒数量相对较高(以载脂蛋白[apo]B估算)而胆固醇(C)含量较低。由于最近的流行病学研究表明,血清apo B比LDL-C更能有力地预测冠心病(CHD)风险,我们推测apo B对CHD的这种强大预测能力归因于其与sd LDL浓度密切相关。另一方面,非HDL-C已被提议作为包含所有致动脉粥样硬化的含apo B脂蛋白的综合CHD风险标志物。我们研究了哪种apo B或非HDL-C在反映sd-LDL颗粒方面是更优的标志物。对81名血脂异常患者进行了研究。通过超速离心法分离sd LDL(密度,1.044约至0.063g/ml)和大而轻的LDL(密度,1.019约至1.044g/ml),并通过梯度凝胶电泳测量LDL大小。LDL-C、非HDL-C和apo B彼此高度相关(r = 0.78约至0.87),并且所有这些都与sd-LDL中的C、apo B和甘油三酯(TG)相关。然而,多变量回归分析显示,只有apo B始终且独立地与sd-LDL浓度相关。平均LDL直径与apo B呈负相关,但与非HDL-C无关。这些结果表明,在反映一种强效致动脉粥样硬化脂蛋白sd-LDL方面,apo B优于非HDL-C,这可能解释了apo B对CHD的强大预测能力。

相似文献

1
[Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].[小而密低密度脂蛋白浓度与血清载脂蛋白B密切相关,非低密度脂蛋白胆固醇或低密度脂蛋白胆固醇的比较]
Rinsho Byori. 2006 Jun;54(6):569-75.
2
[Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].[血清载脂蛋白B在预测土耳其人冠心病发病方面优于低密度脂蛋白胆固醇水平]
Anadolu Kardiyol Derg. 2007 Jun;7(2):128-33.
3
Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.载脂蛋白B、低密度脂蛋白胆固醇与男性冠心病的长期风险
Am J Cardiol. 2006 Apr 1;97(7):997-1001. doi: 10.1016/j.amjcard.2005.10.060. Epub 2006 Feb 13.
4
Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.非高密度脂蛋白胆固醇对冠心病的相对致动脉粥样硬化性及预测价值
Am J Cardiol. 2008 Apr 1;101(7):1003-8. doi: 10.1016/j.amjcard.2007.11.046.
5
Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?低密度脂蛋白大小在预测致命性心肌梗死风险时是否会增加致动脉粥样硬化颗粒数量?
Am J Cardiol. 2006 Apr 1;97(7):943-6. doi: 10.1016/j.amjcard.2005.10.062. Epub 2006 Feb 13.
6
Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.强化胰岛素治疗可降低2型糖尿病患者的小而密低密度脂蛋白颗粒:与富含甘油三酯的脂蛋白亚类的关系。
Metabolism. 2006 Jul;55(7):879-84. doi: 10.1016/j.metabol.2006.02.014.
7
Relationship between plasma lipid concentrations and HDL subclasses.血浆脂质浓度与高密度脂蛋白亚类之间的关系。
Clin Chim Acta. 2005 Apr;354(1-2):49-58. doi: 10.1016/j.cccn.2004.11.015. Epub 2004 Dec 24.
8
LDL molecular size as risk factor in coronary artery disease.低密度脂蛋白分子大小作为冠状动脉疾病的危险因素。
Acta Med Hung. 1992;49(1-2):65-77.
9
The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.饮食控制下苯丙酮尿症患者血清脂质、脂蛋白和载脂蛋白与特定微量元素及矿物质的关联
Clin Nutr. 2004 Jun;23(3):401-7. doi: 10.1016/j.clnu.2003.09.006.
10
Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.超越低密度脂蛋白胆固醇:界定低密度脂蛋白异质性在冠状动脉疾病中的作用
J Am Coll Cardiol. 2007 Oct 30;50(18):1735-41. doi: 10.1016/j.jacc.2007.07.045. Epub 2007 Oct 15.

引用本文的文献

1
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.载脂蛋白B与心血管疾病:生物标志物及潜在治疗靶点
Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690.
2
Novel and traditional lipid profiles in Metabolic Syndrome reveal a high atherogenicity.代谢综合征的新型和传统脂质谱揭示了高度的动脉粥样硬化性。
Sci Rep. 2019 Aug 13;9(1):11792. doi: 10.1038/s41598-019-48120-5.
3
High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis.高风险牙周病原体促成动脉粥样硬化的发病机制。
Postgrad Med J. 2017 Apr;93(1098):215-220. doi: 10.1136/postgradmedj-2016-134279. Epub 2016 Nov 29.
4
LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.在终末期肾病患者中,与 LDL 胆固醇和风险分类相比,LDL 颗粒大小和数量。
J Nephrol. 2011 Nov-Dec;24(6):771-7. doi: 10.5301/JN.2011.6376.